E. Gold

No ORCID on file · 2 papers in corpus · active 1992-1993

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 1
other 1993
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia
The Journal of endocrinology ·doi:10.1677/joe.0.1370027

In women with endometriosis there is concern that therapeutic use of LH-releasing hormone (LHRH) analogues, to lower ovarian oestrogen production and control endometrial hyperplasia, leads to unwanted oestrogen-deficiency bone loss. We have…

article 1992
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin
Bone and mineral ·doi:10.1016/0169-6009(92)90854-7

In young women chronic use of luteinizing hormone releasing hormone (LHRH) agonists such as buserelin to treat endometriosis leads to estrogen-deficiency bone loss. Tamoxifen citrate is an estrogen agonist/antagonist which protects the skel…